errr, so AVX net outflows last quarter were $0.89M
and as of about Sept, AVX had made $0.8M in investment returns for the qtr...!!!
even forgetting about the Allied returns...!!!
cash flow positive this qtr??? v nice...
could be cash flow very positive next qtr with a juicy upfront partner payment...
"Armed with this information Avexa’s Board has been both actively marketing ATC to a wide range of pharmaceutical companies – large, specialist and niche – and looking at alternative strategies to complete the clinical development and obtain a marketing approval. At the time of this report, these activities are in full swing, including the
steps required to obtain agreement with the European regulatory agencies for ATC."
Add to My Watchlist
What is My Watchlist?